161 related articles for article (PubMed ID: 30273843)
1. Low glucagon-like peptide-1 (GLP-1) concentration in serum is indicative of mild cognitive impairment in type 2 diabetes patients.
Wu P; Zhao Y; Zhuang X; Sun A; Zhang Y; Ni Y
Clin Neurol Neurosurg; 2018 Nov; 174():203-206. PubMed ID: 30273843
[TBL] [Abstract][Full Text] [Related]
2. Age Related Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients in the Indian Population and Association of Serum Lipids With Cognitive Dysfunction.
Chakraborty A; Hegde S; Praharaj SK; Prabhu K; Patole C; Shetty AK; Mayya SS; Acharya RV; Hande HM; Prabhu MM; Upadhya D
Front Endocrinol (Lausanne); 2021; 12():798652. PubMed ID: 35035379
[TBL] [Abstract][Full Text] [Related]
3. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
[TBL] [Abstract][Full Text] [Related]
4. Non-high-density lipoprotein cholesterol and other risk factors of mild cognitive impairment among Chinese type 2 diabetic patients.
Niu MJ; Yin FZ; Liu LX; Fang Y; Xuan XM; Wu GF
J Diabetes Complications; 2013; 27(5):443-6. PubMed ID: 23845902
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: a cross-section study.
Chen RH; Jiang XZ; Zhao XH; Qin YL; Gu Z; Gu PL; Zhou B; Zhu ZH; Xu LY; Zou YF
Ann Endocrinol (Paris); 2012 Jun; 73(3):208-12. PubMed ID: 22704263
[TBL] [Abstract][Full Text] [Related]
6. Low serum apelin levels are associated with mild cognitive impairment in Type 2 diabetic patients.
Jiang Y; Wang S; Liu X
BMC Endocr Disord; 2022 May; 22(1):137. PubMed ID: 35610700
[TBL] [Abstract][Full Text] [Related]
7. [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].
Cui T; Ren Y; Ma H; Liu SF; Zhang XX; Yu HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):774-8. PubMed ID: 24325110
[TBL] [Abstract][Full Text] [Related]
8. Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.
Wang J; Yuan Y; Cai R; Huang R; Tian S; Lin H; Guo D; Wang S
J Alzheimers Dis; 2018; 63(2):835-845. PubMed ID: 29689724
[TBL] [Abstract][Full Text] [Related]
9. Analysis of correlation between the mild cognitive impairment (MCI) and level of adiponectin in elderly patients with type 2 diabetes mellitus (T2DM).
Liu ZQ; Zhang MX; Wang J; Ding N
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5471-5477. PubMed ID: 29243792
[TBL] [Abstract][Full Text] [Related]
10. Impaired secretion of active GLP-1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm?
Wang X; Liu J; Li C; Zhao M; Liu L; Guan Q; Zhang H; Zhang X; Gao L; Zhao J; Song Y
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29135069
[TBL] [Abstract][Full Text] [Related]
11. Inverted U-shaped correlation between serum low-density lipoprotein cholesterol levels and cognitive functions of patients with type 2 diabetes mellitus.
Zhang H; Zhu W; Niu T; Wang Z; An K; Cao W; Shi J; Wang S
Lipids Health Dis; 2021 Sep; 20(1):103. PubMed ID: 34511118
[TBL] [Abstract][Full Text] [Related]
12. Elevated Plasma Free Fatty Acid Susceptible to Early Cognitive Impairment in Type 2 Diabetes Mellitus.
Zhu W; Xu L; Zhang H; Tian S; An K; Cao W; Shi J; Tang W; Wang S
J Alzheimers Dis; 2021; 82(3):1345-1356. PubMed ID: 34151809
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
14. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
Cuthbertson J; Patterson S; O'Harte FP; Bell PM
Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
[TBL] [Abstract][Full Text] [Related]
15. Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients.
de Luis DA; Aller R; Izaola O; Bachiller R
J Endocrinol Invest; 2015 Feb; 38(2):143-7. PubMed ID: 25200998
[TBL] [Abstract][Full Text] [Related]
16. Potential roles of Glucagon-like peptide-1 and its analogues in cognitive impairment associated with type 2 diabetes mellitus.
Yu ZW; Liu R; Li X; Wang Y; Fu YH; Li HY; Yuan Y; Gao XY
Mech Ageing Dev; 2020 Sep; 190():111294. PubMed ID: 32585235
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes.
Sun L; Diao X; Gang X; Lv Y; Zhao X; Yang S; Gao Y; Wang G
J Diabetes Res; 2020; 2020():4591938. PubMed ID: 32377520
[TBL] [Abstract][Full Text] [Related]
18. The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus.
Lastya A; Saraswati MR; Suastika K
BMC Res Notes; 2014 Nov; 7():849. PubMed ID: 25427660
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma Interleukin-1β level is associated with memory deficits in type 2 diabetic patients with mild cognitive impairment.
Tian S; Huang R; Han J; Cai R; Guo D; Lin H; Wang J; Wang S
Psychoneuroendocrinology; 2018 Oct; 96():148-154. PubMed ID: 29957442
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study.
Liu Y; Zhong X; Shen J; Jiao L; Tong J; Zhao W; Du K; Gong S; Liu M; Wei M
Brain Res; 2020 Jan; 1727():146554. PubMed ID: 31765631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
